Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.70B
Market cap12.70B
Price-Earnings ratio
78.88
Price-Earnings ratio78.88
Dividend yield
Dividend yield
Average volume
423.07K
Average volume423.07K
High today
High today
Low today
Low today
Open price
$320.23
Open price$320.23
Volume
0.00
Volume0.00
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

The current Penumbra(PEN) stock price is $321.19, with a market capitalization of 12.7B. The stock trades at a price-to-earnings (P/E) ratio of 78.88.

Penumbra(PEN) stock opened on 2026-08-03 at $320.23. The price climbed to — and dipped to —.

Penumbra(PEN) shares are trading with a volume of 0, against a daily average of 423.07K.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

PEN News

Investing.com 4d
Penumbra Inc earnings missed by $0.28, revenue topped estimates - Investing.com

...

Penumbra Inc earnings missed by $0.28, revenue topped estimates - Investing.com
Simply Wall St 6d
Penumbra Wins Early THUNDERBOLT Use, Is The 12% Discount Below Fair Value Enough?

Penumbra (PEN) is back on investor radar after Novant Health reported successful clinical use of its newly cleared THUNDERBOLT computer assisted vacuum thrombec...

Penumbra Wins Early THUNDERBOLT Use, Is The 12% Discount Below Fair Value Enough?

Analyst ratings

92%

of 12 ratings
Buy
8.3%
Hold
91.7%
Sell
0%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.